{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:33:06Z","timestamp":1781839986224,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00066-019-01541-7","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T16:02:31Z","timestamp":1574438551000},"page":"126-131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma","Deeskalierte Strahlentherapie beim indolenten prim\u00e4r kutanen B-Zell-Lymphom"],"prefix":"10.1007","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2786-7013","authenticated-orcid":false,"given":"Michael","family":"Oertel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Elsayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Weishaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Steinbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Theodor","family":"Eich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"key":"1541_CR1","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/ddg.13372","volume":"15","author":"E Dippel","year":"2017","unstructured":"Dippel\u00a0E, Assaf\u00a0C, Becker\u00a0JC et\u00a0al (2017) S2k guidelines\u2014cutaneous lymphomas update 2016\u2014part 1: classification and diagnosis (ICD10 C82\u2013C86): German guidelines for cutaneous lymphomas. J\u00a0Dtsch Dermatol Ges 15:1266\u20131273. https:\/\/doi.org\/10.1111\/ddg.13372","journal-title":"J Dtsch Dermatol Ges"},{"key":"1541_CR2","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1111\/ddg.13164","volume":"14","author":"JP Nicolay","year":"2016","unstructured":"Nicolay\u00a0JP, Wobser\u00a0M (2016) Cutaneous B\u2011cell lymphomas\u2014pathogenesis, diagnostic workup, and therapy. J\u00a0Dtsch Dermatol Ges 14:1207\u20131224. https:\/\/doi.org\/10.1111\/ddg.13164","journal-title":"J Dtsch Dermatol Ges"},{"issue":"iv30","key":"1541_CR3","doi-asserted-by":"publisher","first-page":"iv40","DOI":"10.1093\/annonc\/mdy133","volume":"29","author":"R Willemze","year":"2018","unstructured":"Willemze\u00a0R, Hodak\u00a0E, Zinzani\u00a0PL et al (2018) Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(iv30):iv40. https:\/\/doi.org\/10.1093\/annonc\/mdy133","journal-title":"Ann Oncol"},{"key":"1541_CR4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-881268","author":"R Willemze","year":"2019","unstructured":"Willemze\u00a0R, Cerroni\u00a0L, Kempf\u00a0W et al (2019) The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. https:\/\/doi.org\/10.1182\/blood-2018-11-881268","journal-title":"Blood"},{"key":"1541_CR5","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","volume":"112","author":"NJ Senff","year":"2008","unstructured":"Senff\u00a0NJ, Noordijk\u00a0EM, Kim\u00a0YH et al (2008) European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B\u2011cell lymphomas. Blood 112:1600\u20131609. https:\/\/doi.org\/10.1182\/blood-2008-04-152850","journal-title":"Blood"},{"key":"1541_CR6","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"World Health Organization","year":"2017","unstructured":"World Health Organization (2017) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer, Lyon (revised 4th edn)"},{"key":"1541_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/ddg.13401","volume":"16","author":"E Dippel","year":"2018","unstructured":"Dippel\u00a0E, Assaf\u00a0C, Becker\u00a0JC et al (2018) S2k guidelines\u2014cutaneous lymphomas update 2016\u2014part 2: treatment and follow-up (ICD10 C82\u2013C86): German guidelines for cutaneous lymphomas. J\u00a0Dtsch Dermatol Ges 16:112\u2013122. https:\/\/doi.org\/10.1111\/ddg.13401","journal-title":"J Dtsch Dermatol Ges"},{"key":"1541_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ijrobp.2015.01.008","volume":"92","author":"L Specht","year":"2015","unstructured":"Specht\u00a0L, Dabaja\u00a0B, Illidge\u00a0T et\u00a0al (2015) Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 92:32\u201339. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1541_CR9","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/bjd.16783","volume":"179","author":"L Christensen","year":"2018","unstructured":"Christensen\u00a0L, Cooper\u00a0K, Honda\u00a0K, Mansur\u00a0D (2018) Relapse rates in patients with unilesional primary cutaneous B\u2011cell lymphoma treated with radiation therapy: a\u00a0single-institution experience. Br J Dermatol 179:1172\u20131173. https:\/\/doi.org\/10.1111\/bjd.16783","journal-title":"Br J Dermatol"},{"key":"1541_CR10","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s00277-018-3471-x","volume":"97","author":"F De Felice","year":"2018","unstructured":"De Felice\u00a0F, Grapulin\u00a0L, Pieroni\u00a0A et\u00a0al (2018) Radiation therapy in indolent primary cutaneous B cell lymphoma: a\u00a0single institute experience. Ann Hematol 97:2411\u20132416. https:\/\/doi.org\/10.1007\/s00277-018-3471-x","journal-title":"Ann Hematol"},{"key":"1541_CR11","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0360-3016(02)04199-8","volume":"55","author":"HT Eich","year":"2003","unstructured":"Eich\u00a0HT, Eich\u00a0D, Micke\u00a0O et al (2003) Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B\u2011cell lymphoma. Int J Radiat Oncol Biol Phys 55:899\u2013906","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1541_CR12","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1111\/jdv.14972","volume":"32","author":"M-L Gauci","year":"2018","unstructured":"Gauci\u00a0M\u2011L, Quero\u00a0L, Ram-Wolff\u00a0C et al (2018) Outcomes of radiation therapy of indolent cutaneous B\u2011cell lymphomas and literature review. J\u00a0Eur Acad Dermatol Venereol 32:1668\u20131673. https:\/\/doi.org\/10.1111\/jdv.14972","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1541_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jaad.2017.07.053","volume":"78","author":"A Goyal","year":"2018","unstructured":"Goyal\u00a0A, Carter\u00a0JB, Pashtan\u00a0I et al (2018) Very low-dose versus standard dose radiation therapy for indolent primary cutaneous B\u2011cell lymphomas: a retrospective study. J\u00a0Am Acad Dermatol 78:408\u2013410. https:\/\/doi.org\/10.1016\/j.jaad.2017.07.053","journal-title":"J Am Acad Dermatol"},{"key":"1541_CR14","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/archderm.141.9.1139","volume":"141","author":"JJ Hoefnagel","year":"2005","unstructured":"Hoefnagel\u00a0JJ, Vermeer\u00a0MH, Jansen\u00a0PM et al (2005) Primary cutaneous marginal zone B\u2011cell lymphoma: clinical and therapeutic features in 50 cases. Arch Dermatol 141:1139\u20131145. https:\/\/doi.org\/10.1001\/archderm.141.9.1139","journal-title":"Arch Dermatol"},{"key":"1541_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0167-8140(99)00089-4","volume":"52","author":"YM Kirova","year":"1999","unstructured":"Kirova\u00a0YM, Piedbois\u00a0Y, Le Bourgeois\u00a0J\u2011P (1999) Radiotherapy in the management of cutaneous B\u2011cell lymphoma. Our experience in 25 cases. Radiother Oncol 52:15\u201318. https:\/\/doi.org\/10.1016\/S0167-8140(99)00089-4","journal-title":"Radiother Oncol"},{"key":"1541_CR16","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3109\/10428194.2012.723707","volume":"54","author":"I Pashtan","year":"2013","unstructured":"Pashtan\u00a0I, Mauch\u00a0PM, Chen\u00a0Y\u2011H et al (2013) Radiotherapy in the management of localized primary cutaneous B\u2011cell lymphoma. Leuk Lymphoma 54:726\u2013730. https:\/\/doi.org\/10.3109\/10428194.2012.723707","journal-title":"Leuk Lymphoma"},{"key":"1541_CR17","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","volume":"143","author":"NJ Senff","year":"2007","unstructured":"Senff\u00a0NJ, Hoefnagel\u00a0JJ, Neelis\u00a0KJ et al (2007) Results of radiotherapy in 153 primary cutaneous B\u2011Cell lymphomas classified according to the WHO-EORTC classification. Arch Dermatol 143:1520\u20131526. https:\/\/doi.org\/10.1001\/archderm.143.12.1520","journal-title":"Arch Dermatol"},{"key":"1541_CR18","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1200\/JCO.2004.08.044","volume":"22","author":"BD Smith","year":"2004","unstructured":"Smith\u00a0BD, Glusac\u00a0EJ, McNiff\u00a0JM et al (2004) Primary cutaneous B\u2011cell Lymphoma treated with radiotherapy: a comparison of the European organization for research and treatment of cancer and the WHO classification systems. J\u00a0Clin Oncol 22:634\u2013639. https:\/\/doi.org\/10.1200\/JCO.2004.08.044","journal-title":"J Clin Oncol"},{"key":"1541_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3109\/10428194.2015.1040012","volume":"57","author":"M Akhtari","year":"2016","unstructured":"Akhtari\u00a0M, Reddy\u00a0JP, Pinnix\u00a0CC et al (2016) Primary cutaneous B\u2011cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy. Leuk Lymphoma 57:34\u201338. https:\/\/doi.org\/10.3109\/10428194.2015.1040012","journal-title":"Leuk Lymphoma"},{"key":"1541_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","volume":"15","author":"PJ Hoskin","year":"2014","unstructured":"Hoskin\u00a0PJ, Kirkwood\u00a0AA, Popova\u00a0B et al (2014) 4\u202fGy versus 24\u202fGy radiotherapy for patients with indolent lymphoma (FORT): a\u00a0randomised phase 3 non-inferiority trial. Lancet Oncol 15:457\u2013463. https:\/\/doi.org\/10.1016\/S1470-2045(14)70036-1","journal-title":"Lancet Oncol"},{"key":"1541_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","volume":"100","author":"L Lowry","year":"2011","unstructured":"Lowry\u00a0L, Smith\u00a0P, Qian\u00a0W et al (2011) Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a\u00a0randomised phase III trial. Radiother Oncol 100:86\u201392. https:\/\/doi.org\/10.1016\/j.radonc.2011.05.013","journal-title":"Radiother. Oncol."},{"key":"1541_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ijrobp.2008.06.1918","volume":"74","author":"KJ Neelis","year":"2009","unstructured":"Neelis\u00a0KJ, Schimmel\u00a0EC, Vermeer\u00a0MH et al (2009) Low-dose palliative radiotherapy for cutaneous B\u2011 and T\u2011cell lymphomas. Int J Radiat Oncol Biol Phys 74:154\u2013158. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.06.1918","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1541_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-019-01538-2","volume-title":"Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patients. Strahlenther Onkol","author":"K Elsayad","year":"2019","unstructured":"Elsayad K, Reinartz G, Oertel M et al (2019) Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patients. Strahlenther Onkol. https:\/\/doi.org\/10.1007\/s00066-019-01538-2"},{"key":"1541_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00277-010-1083-1","volume":"90","author":"M Mian","year":"2011","unstructured":"Mian\u00a0M, Marcheselli\u00a0L, Luminari\u00a0S et\u00a0al (2011) CLIPI: a\u00a0new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11). Ann Hematol 90:401\u2013408. https:\/\/doi.org\/10.1007\/s00277-010-1083-1","journal-title":"Ann Hematol"},{"key":"1541_CR25","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s00066-016-0962-3","volume":"192","author":"L K\u00f6nig","year":"2016","unstructured":"K\u00f6nig\u00a0L, Stade\u00a0R, Rieber\u00a0J et\u00a0al (2016) Radiotherapy of indolent orbital lymphomas: two radiation concepts. Strahlenther Onkol 192:414\u2013421. https:\/\/doi.org\/10.1007\/s00066-016-0962-3","journal-title":"Strahlenther Onkol"},{"key":"1541_CR26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s00066-018-1277-3","volume":"194","author":"L K\u00f6nig","year":"2018","unstructured":"K\u00f6nig\u00a0L, H\u00f6rner-Rieber\u00a0J, Bernhardt\u00a0D et al (2018) Response rates and recurrence patterns after low-dose radiotherapy with 4\u202fGy in patients with low-grade lymphomas. Strahlenther Onkol 194:454\u2013461. https:\/\/doi.org\/10.1007\/s00066-018-1277-3","journal-title":"Strahlenther Onkol"},{"key":"1541_CR27","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1365-2133.2008.08992.x","volume":"160","author":"F Sampogna","year":"2009","unstructured":"Sampogna\u00a0F, Frontani\u00a0M, Baliva\u00a0G et\u00a0al (2009) Quality of life and psychological distress in patients with cutaneous lymphoma. Br J Dermatol 160:815\u2013822. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08992.x","journal-title":"Br J Dermatol"},{"key":"1541_CR28","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ijrobp.2013.07.019","volume":"87","author":"SN Hamilton","year":"2013","unstructured":"Hamilton\u00a0SN, Wai\u00a0ES, Tan\u00a0K et al (2013) Treatment and outcomes in patients with primary cutaneous B\u2011cell lymphoma: the BC cancer agency experience. Int J Radiat Oncol Biol Phys 87:719\u2013725. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.07.019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1541_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000470845","volume":"40","author":"B Dabaja","year":"2017","unstructured":"Dabaja\u00a0B (2017) Renaissance of low-dose radiotherapy concepts for cutaneous lymphomas. Oncol Res Treat 40:255\u2013260. https:\/\/doi.org\/10.1159\/000470845","journal-title":"Oncol Res Treat"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01541-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-019-01541-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01541-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T00:22:22Z","timestamp":1605918142000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-019-01541-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1541"],"URL":"https:\/\/doi.org\/10.1007\/s00066-019-01541-7","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"assertion":[{"value":"15 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.\u00a0Oertel, K.\u00a0Elsayad, C.\u00a0Weishaupt, K.\u00a0Steinbrink, and H.T.\u00a0Eich declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}